Tom Lowery, Ph.D. has served as our Chief Scientific Officer since September 2013. Since joining our company as the first employee in February 2007, Tom has held various technical leadership roles, including assay, methods, reagents and detector development programs. By applying his extensive experience in cutting edge biochemical and biophysical methods development he played a key role in establishing T2 Biosystems' technical capabilities and in driving the company's product strategy and development. Prior to joining T2 Biosystems, Tom conducted research at the University of California Berkeley focused on developing innovative magnetic resonance based biosensors for molecular imaging. This work was funded by the UC Graduate Research and Education in Adaptive Biotechnology program. Tom earned his Ph.D. in chemistry from the University of California, Berkeley and graduated Summa Cum Laude with a B.S. in Biochemistry and University Honors from Brigham Young University.
Tom has a record of highly productive research that includes authoring six articles as an undergraduate and 16 as a graduate student. His scientific achievements include 49 issued or pending patents, and 30 articles and book chapters in top peer-reviewed journals. These include featured research articles in Science, Clinical Chemistry, and Protein Science, a cover article in Blood, and research articles in journals like Science Translational Medicine, the Proceedings of the National Academies of Sciences USA and Journal of the American Chemical Society. He also authored the two comprehensive book chapters on T2 Biosystems’s technology, entitled “Nanomaterials-based Magnetic Relaxation Switch Biosensors” and “Nuclear Magnetic Resonance Nanotechnology: Applications in Clinical Diagnostics and Monitoring”.